Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Martinez

Showing results (371-380 of 463) with videos related to

Pageof 47
Sort By:
Ebiomedicine|May 28, 2026
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosisElena Ellmeier, Alyssa Schnabl, Julia Meissel, et al.
Neurosurgery|November 28, 2018
A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in CraniopharyngiomasShingo Fujio, Tareq A Juratli, Kazunori Arita, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2026
Short-cycle three-day-per-week efavirenz/emtricitabine/tenofovir disoproxil fumarate therapy: a seven-year extension studyBeatriz Borjabad, Jhon Rojas, Alexy Inciarte, et al.
Nature Medicine|April 20, 2026
Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trialIgnacio Melero, Tamara Tanos, Emiliano Calvo Aller, et al.
Archives of Neurology|March 14, 2007
LRRK2 exon 41 mutations in sporadic Parkinson disease in EuropeansSuzanne Lesage, Sabine Janin, Ebba Lohmann, et al.
Journal of Hematology & Oncology|January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphomaLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Science Translational Medicine|May 10, 2023
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumorsIgnacio Melero, Tamara Tanos, Mariana Bustamante, et al.
Pediatric Radiology|March 1, 2019
Joint European Society of Paediatric Radiology (ESPR) and International Society for Forensic Radiology and Imaging (ISFRI) guidelines: paediatric postmortem computed tomography imaging protocolSusan C Shelmerdine, Chandra Y Gerrard, Padma Rao, et al.
Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.
The Lancet. Oncology|May 1, 2018
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trialSonia Pernas, Miguel Martin, Peter A Kaufman, et al.
Pageof 47

Showing results (371-380 of 463) with videos related to

Sort By:
Pageof 47
Ebiomedicine|May 28, 2026
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosisElena Ellmeier, Alyssa Schnabl, Julia Meissel, et al.
Neurosurgery|November 28, 2018
A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in CraniopharyngiomasShingo Fujio, Tareq A Juratli, Kazunori Arita, et al.
The Journal of Antimicrobial Chemotherapy|February 12, 2026
Short-cycle three-day-per-week efavirenz/emtricitabine/tenofovir disoproxil fumarate therapy: a seven-year extension studyBeatriz Borjabad, Jhon Rojas, Alexy Inciarte, et al.
Nature Medicine|April 20, 2026
Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trialIgnacio Melero, Tamara Tanos, Emiliano Calvo Aller, et al.
Archives of Neurology|March 14, 2007
LRRK2 exon 41 mutations in sporadic Parkinson disease in EuropeansSuzanne Lesage, Sabine Janin, Ebba Lohmann, et al.
Journal of Hematology & Oncology|January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphomaLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Science Translational Medicine|May 10, 2023
A first-in-human study of the fibroblast activation protein-targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumorsIgnacio Melero, Tamara Tanos, Mariana Bustamante, et al.
Pediatric Radiology|March 1, 2019
Joint European Society of Paediatric Radiology (ESPR) and International Society for Forensic Radiology and Imaging (ISFRI) guidelines: paediatric postmortem computed tomography imaging protocolSusan C Shelmerdine, Chandra Y Gerrard, Padma Rao, et al.
Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.
The Lancet. Oncology|May 1, 2018
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trialSonia Pernas, Miguel Martin, Peter A Kaufman, et al.
Pageof 47